维普期刊资源整合服务平台（V6.5）

34篇 您的检索式：作者名="FESTUCCIA C"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Effects of EGFR tyrosine kinase inhibitor erlotinib in prostate canc- er cells in vitro 显示文摘	Festuccia C Gravina G L Biordi L	2009	Prostate2009，69，14：	1
2	Osteopontin modulates prostate carcinoma invasive capacity through RGD-dependent upregulation of plasminogen activators显示文摘	Angelucci A Festuccia C D'Andrea G	2002	Biol Chem2002，383，1：	1
3	Trifluoroibuprofen inhibits alpha - methylacyl coenzyme A racemase ( AM- ACR/P504S), reduces cancer cell proliferation and inhibits in vivo tumor growth in aggressive prostate cancer models 显示文摘	FESTUCCIA C GRAVINA G L MANCINI A	2014	Anti- cancer Agents Med Chem2014，14，7：	1
4	Invitro and in vivo effects of bicalutamide on the expres-sion of TrkA and P75 neurotrophin receptors in pros-tate carcinoma显示文摘	FESTUCCIA C GRAVINA G L MUZI P	2007	Prostate2007，67，：	1
5	Plasminogen activator system modulates invasive capacity and proliferation in prostatic tumor cells 显示文摘	Festuccia C Dolo V Gueerra F	1998	Clin Exp Metastasis1998，16，6：	1
6	Tyrosine kinase inhibitor CEP-701 blocks the NTRK1/NGF receptor and limits the invasive capability of pros-tate cancer cells in vitro 显示文摘	FESTUCCIA C MUZI P GRAVINA G L	2007	Int J Oncol2007，30，：	1
7	In vitro and in vivo effects of bicalutamide on the expression of TrkA and P75 neurotrophin receptors in prostate carcinoma 显示文摘	Festuccia C Gravina GL Muzi P	2007	Prostate2007，67，12：	1
8	In vitro regulation of pericellular proteolysis in prostatic tumor cells treated with bombesin显示文摘	Festuccia C Guerra F D'Ascenzo S	1998	Int J Cancer1998，75，3：	1
9	Osteoblast-drived TGF-beta 1 modulates matrix degrading protease expression and activit), in prostate cancer cells 显示文摘	Festuccia C Angelucei A Gravina GL	2000	Int J Cancer2000，85，3：	1
10	Antitumor effects of saf- fron- derived carotenoids in prostate cancer cell models 显示文摘	Festuccia C Mancini A Gravina G1	2014	Bi- omed Res Int2014，2014，13：	1
11	Molecular aspects of gefitinib antiproliferative and prok-apoptotic effects in PTEN-positire and PTEN-negative prostate cancer cell lines 显示文摘	Festuccia C Muzi P MiUimaggi D	2005	Endocr Relat Cancer2005，12，4：	1
12	Osteopontin modulates prostate carcinoma invasive capacity through RGD-dependent upregulation of plasminogen activators显示文摘	Angelucci A Festuccia C D'Andrea G	2002	Biol Chem2002，383，：	1
13	Tyrosine kinase inhibitor CEP-701 blocks the NTRK1/NGF receptor and limits the invasive capability of prostate cancer cel s in vitro显示文摘	Festuccia C Muzi P Gravina GL Millimaggi D Speca S Dolo V	2007	Int J Oncol2007，30，1：	1
14	Osteopontin enhances the cell proliferation induced by the epidermal growth factor in human prostate cancer cells显示文摘	Angelucci A Festuccia C Gravina GL	2004	Prostate2004，59，2：	1
15	Tyrosine kinase inhibitor CEP-701 blocks the NTRKI/NGF receptor and limits the invasive capability of prostate cancer cells in vitro显示文摘	Festuccia C Muzi P Gravina GL	2007	Int J Oncol2007，30，1：	1
16	Plasminogen Activator System Modulates Invasive Capacity and Proliferation in Prostatic Tumor Cells显示文摘	Festuccia C Dolo V Guerra F		0，，：	1
17	Osteopontin enhances the cell proliferation induced by the epidermal growth factor in human prostate cancer cells显示文摘	Angelucci A Festuccia C Gravina GL	2004	Prostate2004，59，2：	1
18	Osteopontin enhances the cell proliferation induced by the epidermal growth factor in human prostate cancer cells显示文摘	Angelucci A Festuccia C Gravina GL	2004	Prostate2004，59，2：	1
19	Vesicle -as- sociated urokinase plasminogen activator promotes invasion in prostate cancer cell lines 显示文摘	Angelucci A D'Ascenzo S Festuccia C	2000	Clin Exp Metastasis2000，18，2：	1
20	Bicalutamide dose-dependently inhibits proliferation in human prostatic carcinoma cell lines and primary cultures显示文摘	Vicentini C Festuccia C Angelucci A	2002	Anticancer Res2002，22，5：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示